from Reuters: Business News https://ift.tt/2FxLt7l
Tuesday, May 1, 2018
Pfizer sales miss as breast cancer drug disappoints
(Reuters) - Leading U.S. drugmaker Pfizer Inc racked up its biggest miss on sales in a year in the first quarter, hurt by lower-than-expected sales of blockbuster breast cancer drug Ibrance and arthritis drug Xeljanz.
from Reuters: Business News https://ift.tt/2FxLt7l
from Reuters: Business News https://ift.tt/2FxLt7l
Related Posts:
Asian stocks pulled higher by Wall Street jobs rally but China caution prevails- Oil prices stumble on weak China exports hangover
- Mexico accepts U.S. steel demand in USMCA trade deal, but with conditions
- Skechers' 'cool' value gives it room to run like Nike: Barron's
- Scottish private sector output expands, says RBS survey
0 comments:
Post a Comment